These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29957065)

  • 1. Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights.
    Agoni C; Ramharack P; Soliman ME
    Future Med Chem; 2018 Jul; 10(14):1665-1675. PubMed ID: 29957065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Interplay of The Co-administration of Rifampin And Newly Developed Anti-TB Drug: Could It Be a Promising New Line of TB Therapy?
    Agoni C; Ramharack P; Soliman MES
    Comb Chem High Throughput Screen; 2018; 21(6):453-460. PubMed ID: 30009705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.
    Lin W; Mandal S; Degen D; Liu Y; Ebright YW; Li S; Feng Y; Zhang Y; Mandal S; Jiang Y; Liu S; Gigliotti M; Talaue M; Connell N; Das K; Arnold E; Ebright RH
    Mol Cell; 2017 Apr; 66(2):169-179.e8. PubMed ID: 28392175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis.
    Nusrath Unissa A; Hassan S; Indira Kumari V; Revathy R; Hanna LE
    J Mol Graph Model; 2016 Jun; 67():20-32. PubMed ID: 27155814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
    Mori G; Orena BS; Franch C; Mitchenall LA; Godbole AA; Rodrigues L; Aguilar-Pérez C; Zemanová J; Huszár S; Forbak M; Lane TR; Sabbah M; Deboosere N; Frita R; Vandeputte A; Hoffmann E; Russo R; Connell N; Veilleux C; Jha RK; Kumar P; Freundlich JS; Brodin P; Aínsa JA; Nagaraja V; Maxwell A; Mikušová K; Pasca MR; Ekins S
    Tuberculosis (Edinb); 2018 Sep; 112():98-109. PubMed ID: 30205975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening.
    Scharf NT; Molodtsov V; Kontos A; Murakami KS; Garcia GA
    SLAS Discov; 2017 Mar; 22(3):287-297. PubMed ID: 28027449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.
    Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167550
    [No Abstract]   [Full Text] [Related]  

  • 8. Probing the Molecular Mechanism of Rifampin Resistance Caused by the Point Mutations S456L and D441V on Mycobacterium tuberculosis RNA Polymerase through Gaussian Accelerated Molecular Dynamics Simulation.
    Zhang Q; Tan S; Xiao T; Liu H; Shah SJA; Liu H
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis.
    Piccaro G; Pietraforte D; Giannoni F; Mustazzolu A; Fattorini L
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7527-33. PubMed ID: 25288092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of Mycobacterium tuberculosis.
    Singh A; Grover S; Sinha S; Das M; Somvanshi P; Grover A
    J Cell Biochem; 2017 Dec; 118(12):4594-4606. PubMed ID: 28485504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.
    Peek J; Lilic M; Montiel D; Milshteyn A; Woodworth I; Biggins JB; Ternei MA; Calle PY; Danziger M; Warrier T; Saito K; Braffman N; Fay A; Glickman MS; Darst SA; Campbell EA; Brady SF
    Nat Commun; 2018 Oct; 9(1):4147. PubMed ID: 30297823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates.
    Cavusoglu C; Turhan A; Akinci P; Soyler I
    J Clin Microbiol; 2006 Jul; 44(7):2338-42. PubMed ID: 16825346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.
    Molodtsov V; Scharf NT; Stefan MA; Garcia GA; Murakami KS
    Mol Microbiol; 2017 Mar; 103(6):1034-1045. PubMed ID: 28009073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.
    Sebastian J; Swaminath S; Nair RR; Jakkala K; Pradhan A; Ajitkumar P
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insight into multiple RpoB clinical mutants of Mycobacterium tuberculosis: An attempt to probe structural variations in rifampicin binding site underlying drug resistance.
    Srivastava G; Tripathi S; Kumar A; Sharma A
    Int J Biol Macromol; 2018 Dec; 120(Pt B):2200-2214. PubMed ID: 29981823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible Binding of Piperine in Mycobacterium tuberculosis RNA Polymerase and Rifampin Synergism.
    Murase LS; Perez de Souza JV; Meneguello JE; Seixas FAV; Hegeto LA; Scodro RBL; Siqueira VLD; Caleffi Ferracioli KR; Cardoso RF
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.